By MATT SEDENSKY Associated Press Day after day, Hazel Eng sat on her couch, a blank stare on her face. The powerful antipsychotics she was taking often cloaked her in sedation. And when they didn't,...
Day after day, Hazel Eng sat on her couch, a blank stare on her face. The powerful antipsychotics she was taking often cloaked her in sedation. And when they didn’t, the 89-year-old lashed out at her nursing home’s aides with such anger and frequency
BURLINGTON, Mass.--(BUSINESSWIRE)-- Bristol-Myers Squibb/Otsuka’s Abilify and AstraZeneca’s Seroquel Continue To Gain Patient Share as Adjunctive Major Depressive Disorder Treatments, According to Findings ...
BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to the generic erosion of blockbuster agents, the unipolar depression drug marketâ
TUESDAY, Sept. 27 (HealthDay News) -- Even though off-label use of atypical antipsychotic drugs is common, a new review finds that such use is only effective in a few conditions and can be harmful in others.